Neurocrine Biosciences, Inc.San Diego, California, United States
Disclosure information not submitted.
SAT-465 - Long-Term Crinecerfont Treatment Reduced ACTH and 17-Hydroxyprogesterone and Improved Clinical Outcomes in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: 2-Year Results from Cahtalyst™ Pediatric
Saturday, June 13, 20269:30 AM - 4:30 PM CT
SUN-458 - Adults with Classic Congenital Adrenal Hyperplasia Taking Crinecerfont Demonstrated Sustained Decreases in Glucocorticoid Doses: 2-Year Results from the Cahtalyst™ Adult Study
Sunday, June 14, 20269:00 AM - 4:00 PM CT
SUN-465 - Long-Term Crinecerfont Enables Sustained Decreases in Glucocorticoid Doses and Improves Clinical Outcomes in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: 2-Year Results from Cahtalyst™ Pediatric
SUN-467 - A Cross-Sectional Survey on Crinecerfont and Quality of Life of Adults with Classic Congenital Adrenal Hyperplasia (CAH) in the United States (US) Participating in Cahtalyst Adult Open-Label Extension (OLE) Study
SUN-468 - Bone Outcomes in Adults with Classic Congenital Adrenal Hyperplasia Treated with Crinecerfont for Up to 2 Years in Cahtalyst™ Adult Study
ORF32-02 - Long-Term Risk of Cardiometabolic Comorbidities Associated with Glucocorticoid Exposure and Androgen Control in Classic Congenital Adrenal Hyperplasia: A Cox Proportional Hazards Analysis from the CAHtalog™ Registry
Sunday, June 14, 20261:50 PM - 1:55 PM CT
ORF32-05 - Characterization of Children and Adolescents with Classic CAH WHO Had Slowed Bone Age Progression and Improved Height Prediction with Crinecerfont
Sunday, June 14, 20262:25 PM - 2:40 PM CT
ORF32-07 - Crinecerfont Improves Weight-Related Outcomes and Insulin Resistance in Adults with Classic Congenital Adrenal Hyperplasia: 2-Year Results from the CAHtalyst™ Adult Study
Sunday, June 14, 20262:55 PM - 3:10 PM CT
MON-495 - Long-Term Risk of Cardiometabolic Comorbidities Associated with Glucocorticoid Exposure and Androgen Control in Classic Congenital Adrenal Hyperplasia: A Cox Proportional Hazards Analysis from the CAHtalog™ Registry
Monday, June 15, 20269:00 AM - 2:00 PM CT
.jpg)
.jpg)